Maxwell Hubert Antwi

Mr. Maxwell Hubert Antwi

Medical Laboratory Science, Koforidua Technical University, Koforidua, Eastern, Ghana
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2021 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Closed access
DSDorcas Serwaa
Dorcas Serwaa
FOFelix Osei-Boakye
Felix Osei-Boakye
CNCharles Nkansah
Charles Nkansah
SASelasie Ahiatrogah
Selasie Ahiatrogah
ELEmmanuel Lamptey
Emmanuel Lamptey
MDMark Danquah
Mark Danquah
Health-care professionals in Ghana were among the prioritized high-risk groups to be administered with the initial supply of Oxford/AstraZeneca vaccine procured by the Government of Ghana. This study sought to assess and identify the determinants of COVID-19 vaccine short-term side effects among health-care workers. A cross-sectional study was conducted on 654 Ghanaian healthcare workers between 16th March and 5th May 2021. The study included health-care workers in registered health settings, who had been vaccinated against COVID-19 and consented to participate in the survey. Descriptive statistics, binary and multivariable logistic regression analyses were executed using SPSS version 22 at p < .05. The findings revealed that, 528 (80.7%) of the participants experienced adverse reactions, which lasted between 0 and 2 days among, 347 (53.1%) of the study participants. The most reported adverse reactions were general body weakness, 434 (32.0%), headache 371 (27.3%), and fever, 257 (19.1%). Health workers aged 35–39 and 40–44 years had lower odds of adverse reactions compared with those aged 25–29 years (aOR: 0.34, 95% C.I. 0.186,0.621, p < .001) and (aOR: 0.42, 95% C.I. 0.201,0.890, p = .023). Taking analgesics before vaccination decreased the likelihood of adverse reactions (aOR: 0.28, 95% C.I. 0.185,0.427, p < .001). High prevalence of adverse reactions was found among the healthcare workers, however short-lived. The most reported systemic adverse reactions were general body weakness, headache, and fever. We recommend intensification of campaigns on COVID-19 vaccines and their associated adverse effects to avoid the negative implication on uptake among the healthcare workers and the general population.

25 July 2025 in Alzheimer's & Dementia
Verified
Journal Article
Open access
MAMaxwell Hubert Antwi
Maxwell Hubert Antwi
ABAnsumana Bockarie
Ansumana Bockarie
GOGeorge Nkrumah Osei
George Nkrumah Osei
DDDavid Mawutor Donkor
David Mawutor Donkor
DSDavid Larbi Simpong
David Larbi Simpong
BACKGROUND: Cytokines and immune markers are critical in mediating inflammation associated with neurodegenerative disease. This review analyzes the role of inflammatory cytokines and immune markers in neurodegeneration among African populations. METHODS: Following Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines, we conducted a systematic review of studies examining cytokine levels in neurodegenerative diseases, focusing on populations of African ancestry. RESULTS: Cytokines like interleukin (IL)‐6, soluble tumor necrosis factor receptor 1, plasma brain‐derived neurotrophic factor, and IL‐8. IL‐6 emerged as a key pro‐inflammatory marker linked to neurodegenerative diseases and cognitive decline, showing stronger correlations in African ancestry populations compared to Caucasians. Genetic findings revealed triggering receptor expressed on myeloid cells 2 variants and Fc fragment of IgG receptor IIb rs1050501 genotypes as influential in Alzheimer's disease (AD)‐related inflammation, alongside a unique correlation between immunoglobulin G index inflammatory markers and AD in African ancestry populations. DISCUSSION: The findings emphasize the crucial role of cytokines in the pathophysiology of neurodegenerative diseases. Understanding their variations among African populations can inform targeted therapeutic strategies and improve patient outcomes. Highlights: Interleukin (IL)‐6 was identified as a key pro‐inflammatory marker, consistently linked to Alzheimer's disease (AD), Parkinson's disease, and dementia, underscoring its significant role in neurodegenerative disease progression. Brain‐derived neurotrophic factor levels were associated with improved cognitive performance, particularly in African American participants. Observational studies identified sex‐based differences in IL‐10 levels, particularly among older African American women. The review highlights notable ethnic differences in cytokines like IL‐8, IL‐1β, and soluble tumor necrosis factor receptors, emphasizing their roles in neurodegeneration and cognitive decline in people of African descent. Triggering receptor expressed on myeloid cells 2 variants, immunoglobulin GM allotypes, and Fc fragment of IgG receptor IIb rs1050501 genotypes were found to influence AD‐related inflammation and progression in African ancestry populations.

28 April 2025 in Alzheimer's & Dementia
Verified
Journal Article
Open access
DDDavid Mawutor Donkor
David Mawutor Donkor
EMEsther Marfo
Esther Marfo
ABAnsumana Bockarie
Ansumana Bockarie
ETEdward Jenner Tettevi
Edward Jenner Tettevi
MAMaxwell Hubert Antwi
Maxwell Hubert Antwi
DSDavid Larbi Simpong
David Larbi Simpong
Dementia, a leading cause of global mortality, disproportionately impacts sub‐Saharan Africans due to complex genetic and environmental interactions. This systematic review evaluated dementia risk factors among sub‐Saharan Africans, identifying significant genetic and environmental influences using the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) guidelines. The ATP‐binding cassette subfamily A member 7 (ABCA7) gene, linked to dementia in African Americans, and unique genetic variants like those in A‐kinase anchor protein 9 (AKAP9) and cytidine deaminase (CDA) genes, emerge as potential contributors. Conversely, apolipoprotein E (APOE) ε4 shows lesser impact in older sub‐Saharan Africans. Environmental findings highlight that exposure to air pollution, including nitrogen dioxide and particulate matter increases the likelihood of dementia. These findings highlight the role of genetic and environmental diversity in shaping dementia risk profiles. Strategies such as training health‐care professionals, enhancing funding for research, combating stigma through awareness campaigns, and fostering global collaborations are vital to ensure African representation in dementia studies. These efforts aim to improve the knowledge of dementia tailored to sub‐Saharan Africa's needs.Highlights: The ATP‐binding cassette subfamily A member 7 (ABCA7) gene is strongly associated with dementia risk, particularly in African American populations. Apolipoprotein E (APOE) ε4, a well‐established risk factor for Alzheimer's disease in Western populations, has a lesser impact in older sub‐Saharan Africans, suggesting unique genetic–environment interactions. Exposure to air pollutants, such as nitrogen dioxide and particulate matter, significantly increases dementia risk. The development of dementia in sub‐Saharan Africans is influenced by complex interactions between genetic predispositions and environmental exposures, emphasizing the need for tailored prevention strategies.

25 February 2024 in Health Science Reports
Verified
Journal Article
Open access
VAVictor E. Ali
Victor E. Ali
MAMarvellous O. Asika
Marvellous O. Asika
EEEmmanuel Ebuka Elebesunu
Emmanuel Ebuka Elebesunu
CAChioma Agbo
Chioma Agbo
MAMaxwell Hubert Antwi
Maxwell Hubert Antwi
Background and Aims: The global immunization campaign against COVID‐19 has mandated vaccination certificates, leading to a surge in fake documentation. In Nigeria, the proliferation of counterfeit COVID‐19 vaccination cards, facilitated by unscrupulous health workers, raises critical public health concerns. This research spotlights various forms of this malpractice, analyzes the factors contributing to the circulation of fake vaccination cards, their implications on public health, and provides recommendations for addressing the issue. Methods: Extensive literature review and analysis were conducted to investigate the emergence of fake COVID‐19 vaccination cards in Nigeria. Perspectives from health workers and reports from reputable undercover investigations were examined to identify factors contributing to the circulation of fraudulent records. The research also delved into corruption within the health sector and the impact of low salaries on healthcare workers. Additionally, global instances of fake vaccination cards were explored to provide a comprehensive understanding of the issue. Results: Healthcare workers' vaccine hesitancy, corruption, and inadequate salaries were identified as key contributors to the circulation of fake vaccination cards in Nigeria. Instances of health workers accepting bribes to issue cards without administering vaccines were uncovered. The implications on public health included threats to herd immunity, compromised disease surveillance, erosion of public trust, and reinforcement of vaccine hesitancy. The research also highlighted global challenges with fake vaccination cards, emphasizing the need for international cooperation. Conclusion: Fake vaccination cards in Nigeria poses challenges to public health, affecting the reliability of immunization data and jeopardizing disease control efforts. It is crucial to strengthen healthcare worker engagement, tackle corruption through increased transparency and improved policies, and implement digital vaccination verification systems. International collaboration is essential to establish standardized security measures and verification checkpoints. Addressing flawed vaccination records requires urgent action to enhance vaccination efforts, and safeguard the population from the resurgence of vaccine‐preventable diseases.

2 December 2021 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
DSDorcas Serwaa
Dorcas Serwaa
FBFolasade Adenike Bello
Folasade Adenike Bello
KOKayode O. Osungbade
Kayode O. Osungbade
CNCharles Nkansah
Charles Nkansah
FOFelix Osei-Boakye
Felix Osei-Boakye
Ernest OwusuErnest Owusu
Ernest Owusu
Diabetes mellitus, an endocrine disorder, has been implicated in many including hypogonadism in men. Given the fact that diabetes mellitus is becoming a fast-growing epidemic and the morbidity associated with it is more disabling than the disease itself. This study sought to assess the prevalence of low testosterone levels and predictors in type 2 diabetes mellitus patients and non-diabetic men in a district hospital in Ghana. This hospital-based case-control study comprised 150 type 2 diabetics and 150 healthy men. A pre-structured questionnaire and patient case notes were used to document relevant demographic and clinical information. Venous blood sample of about 6 ml was taken to measure FBS, HbA1c, FSH, LH, and testosterone levels. All data were analyzed using STATA version 12 (STATA Corporation, Texas, USA). The overall hypogonadism in the study population was 48% (144/300). The prevalence of hypogonadism in type 2 diabetic subjects was almost three times more than in healthy men (70.7% vs 25.3%). The odds of having hypogonadism was lower in the men with normal weight and overweight with their underweight counterparts (AOR = 0.33, 95% CI; 0.12–0.96, p = 0.042) and (AOR = 0.29, 95% CI; 0.10–0.84, p = 0.023) respectively. Also, the odds of suffering from hypogonadism was lower in non-smokers compared with smokers (AOR: 0.16, 95% CI; 0.05–0.58, p = 0.005). Participants who were engaged in light (AOR: 0.29, 95% CI; 0.14–0.61, p = 0.001), moderate (AOR: 0.26, 95% CI; 0.13–0.54, p<0.001) and heavy (AOR: 0.25, 95% CI; 0.10–0.67, p = 0.006) leisure time activities had lower odds hypogonadal compared to those engaged in sedentary living. Type 2 diabetic men have high incidence of hypogonadism, irrespective of their baseline clinical, lifestyle or demographic characteristics. Smoking and sedentary lifestyle and BMI were associated with hypogonadism in the study population. Routine testosterone assessment and replacement therapy for high risk patients is recommended to prevent the detrimental effect of hypogonadism in diabetic men.

30 January 2025 in Cells
Verified
Journal Article
Open access
PDF file
Haneef Ahmed AmissahHaneef Ahmed Amissah
Haneef Ahmed Amissah
MAMaxwell Hubert Antwi
Maxwell Hubert Antwi
TATAWFEEK AMISSAH
TAWFEEK AMISSAH
SCStephanie Combs
Stephanie Combs
Maxim ShevtsovMaxim Shevtsov
Maxim Shevtsov
The epichaperome, a dynamic and integrated network of chaperone proteins, extends its roles beyond basic protein folding to protein stabilization and intracellular signal transduction to orchestrating a multitude of cellular processes critical for tumor survival. In this review, we explore the multifaceted roles of the epichaperome, delving into its diverse cellular locations, factors that modulate its formation and function, its liquid–liquid phase separation, and the key signaling and crosstalk pathways it regulates, including cellular metabolism and intracellular signal transduction. We further highlight techniques for isolating and identifying epichaperome networks, pitfalls, and opportunities. Further, we review the profound implications of the epichaperome for cancer treatment and therapy design, underscoring the need for strategic engineering that hinges on a comprehensive insight into the comprehensive structure and workings of the epichaperome across the heterogeneous cell subpopulations in the tumor milieu. By presenting a holistic view of the epichaperome’s functions and mechanisms, we aim to underscore its potential as a key target for novel anti-cancer strategies, revealing that the epichaperome is not merely a piece of protein folding machinery but a mastermind that facilitates the malignant phenotype.